Search

Your search keyword '"Ruiz-Gonzalez I"' showing total 34 results
Start Over Author "Ruiz-Gonzalez I"
34 results on '"Ruiz-Gonzalez I"'

1. [Translated article] Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)

Author

Navarro-Triviño, F.J., Borrego, L., Silvestre-Salvador, J.F., Mercader-García, P., Giménez-Arnau, A.M., Ortiz-de Frutos, F.J., Sanz-Sánchez, T., Melé-Ninot, G., Sánchez-Gilo, A., Zaragoza-Ninet, V., Serra-Baldrich, E., Miquel-Miquel, J., Córdoba-Guijarro, S., Rodríguez-Serna, M., Ruíz-González, I., Carrascosa-Carrillo, J.M., Gómez-de la Fuente, E., Pastor-Nieto, M.A., Heras-Mendaza, F., González-Pérez, R., Sánchez-Pedreño Guillén, P., Sánchez-Pérez, J., Gatica-Ortega, M.E., Fernández-Redondo, V., Hervella-Garcés, M., Manrique-Martínez, P., Guimaraens-Juanena, D., García-Gavín, J., Giménez-Arnau, E., Figueras-Nart, I., Curto-Barredo, L., and Armario-Hita, J.C.

Published
2024
Full Text
View/download PDF

2. Actualización de la batería estándar y batería ampliada de pruebas alérgicas de contacto por el Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC)

Author

Navarro-Triviño, F.J., Borrego, L., Silvestre-Salvador, J.F., Mercader-García, P., Giménez-Arnau, A.M., Ortiz-de Frutos, F.J., Sanz-Sánchez, T., Melé-Ninot, G., Sánchez-Gilo, A., Zaragoza-Ninet, V., Serra-Baldrich, E., Miquel-Miquel, J., Córdoba-Guijarro, S., Rodríguez-Serna, M., Ruíz-González, I., Carrascosa-Carrillo, J.M., Gómez-de la Fuente, E., Pastor-Nieto, M.A., Heras-Mendaza, F., González-Pérez, R., Sánchez-Pedreño Guillén, P., Sánchez-Pérez, J., Gatica-Ortega, M.E., Fernández-Redondo, V., Hervella-Garcés, M., Manrique-Martínez, P., Guimaraens-Juanena, D., García-Gavín, J., Giménez-Arnau, E., Figueras-Nart, I., Curto-Barredo, L., and Armario-Hita, J.C.

Published
2024
Full Text
View/download PDF

3. Perfil epidemiológico, clínico y alérgico en pacientes con psoriasis. Evaluación del Registro Español de Dermatitis de Contacto (REIDAC)

Author

Verdaguer-Faja, J., Borrego, L., Mercader-García, P., González Pérez, R., Córdoba-Guijarro, S., Giménez-Arnau, A.M., Ruiz-González, I., Miquel-Miquel, J., Silvestre, J.F., Ortiz de Frutos, F.J., Tous-Romero, F., Sanz Sánchez, T., Rodríguez-Serna, M., Sánchez-Pérez, J., Serra Baldrich, E., Zaragoza-Ninet, V., Pastor-Nieto, M.A., Gática-Ortega, M.E., Sánchez Gilo, A., Melé-Ninot, G., Sánchez-Pedreño Guillén, P., Munera-Campos, M., Descalzo, M.Á., García-Doval, I., and Carrascosa, J.M.

Published
2024
Full Text
View/download PDF

4. [Translated article] Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC)

Author

Verdaguer-Faja, J., Borrego, L., Mercader-García, P., González Pérez, R., Córdoba-Guijarro, S., Giménez-Arnau, A.M., Ruiz-González, I., Miquel-Miquel, J., Silvestre, J.F., Ortiz de Frutos, F.J., Tous-Romero, F., Sanz Sánchez, T., Rodríguez-Serna, M., Sánchez-Pérez, J., Serra Baldrich, E., Zaragoza-Ninet, V., Pastor-Nieto, M.A., Gática-Ortega, M.E., Sánchez Gilo, A., Melé-Ninot, G., Sánchez-Pedreño Guillén, P., Munera-Campos, M., Descalzo, M.Á., García-Doval, I., and Carrascosa, J.M.

Published
2024
Full Text
View/download PDF

5. [Translated article] Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends

Author

Tous-Romero, F., Borrego-Hernando, L., García-Doval, I., Mercader-García, P., Silvester-Salvador, J.F., Sánchez-Gilo, A., Sanz-Sánchez, T., Giménez-Arnau, A.M., Zaragoza-Ninet, V., Miquel-Miquel, J., González Pérez, R., Córdoba-Guijarro, S., Carrascosa-Carrillo, J.M., Gática-Ortega, M.E., Ruíz-González, I., Serra-Baldrich, E., Pastor-Nieto, A., Rodríguez-Serna, M., Sánchez-Pérez, J., Melé i Ninot, G., Sánchez-Pedreño Guillén, P., and Ortiz-de Frutos, J.

Published
2024
Full Text
View/download PDF

6. Vigilancia epidemiológica en los últimos 4 años del Registro Español de Investigación en Dermatitis de Contacto y Alergia Cutánea: situación actual y tendencias

Author

Tous-Romero, F., Borrego-Hernando, L., García-Doval, I., Mercader-García, P., Silvester-Salvador, J.F., Sánchez-Gilo, A., Sanz-Sánchez, T., Giménez-Arnau, A.M., Zaragoza-Ninet, V., Miquel-Miquel, J., González Pérez, R., Córdoba-Guijarro, S., Carrascosa-Carrillo, J.M., Gática-Ortega, M.E., Ruíz-González, I., Serra-Baldrich, E., Pastor-Nieto, A., Rodríguez-Serna, M., Sánchez-Pérez, J., Melé i Ninot, G., Sánchez-Pedreño Guillén, P., and Ortiz-de Frutos, J.

Published
2024
Full Text
View/download PDF

9. [Translated article] Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

Author

Mora-Fernández, V., Mercader Garcia, P., Borrego Hernando, L., González Pérez, R., Córdoba Guijarro, S., Giménez Arnau, A., Ruiz González, I., Miquel Miquel, F.J., Silvestre Salvador, J.F., Ortiz de Frutos, F.J., Sanz Sanchez, T., Rodríguez Serna, M., Fernández Redondo, V., Sanchez Perez, J., Heras Mendaza, F., Serra Baldrich, E., Zaragoza Ninet, V., Pastor Nieto, M.A., Hervella Garcia, M., Garcia Doval, I., and Carrascosa, J.M.

Published
2022
Full Text
View/download PDF

10. Perfil epidemiológico, clínico, y alérgico en pacientes con dermatitis atópica y dermatitis de las manos. Evaluación del Registro Español de Dermatitis de Contacto (REIDAC)

Author

Mora-Fernández, V., Mercader Garcia, P., Borrego Hernando, L., González Pérez, R., Córdoba Guijarro, S., Giménez Arnau, A., Ruiz González, I., Miquel Miquel, F.J., Silvestre Salvador, J.F., Ortiz de Frutos, F.J., Sanz Sanchez, T., Rodríguez Serna, M., Fernández Redondo, V., Sanchez Perez, J., Heras Mendaza, F., Serra Baldrich, E., Zaragoza Ninet, V., Pastor Nieto, M.A., Hervella Garcia, M., Garcia Doval, I., and Carrascosa, J.M.

Published
2022
Full Text
View/download PDF

11. Alérgenos candidatos para ser incluidos en la serie estándar española a partir de los datos del Registro Español de Dermatitis de Contacto

Author

Hernández-Fernández, C.P., Mercader-García, P., Silvestre Salvador, J.F., Sánchez Pérez, J., Fernández Redondo, V., Miquel Miquel, F.J., Ortiz de Frutos, F.J., Gatica Ortega, M.E., Mora Fernández, V., Giménez Arnau, A.M., Zaragoza Ninet, V., González Pérez, R., Sanz Sánchez, T., Pastor Nieto, M.A., Serra Baldrich, E., Córdoba Guijarro, S., Heras Mendaza, F., Ruiz González, I., Rodríguez Serna, M., Hervella Garcés, M., Gallego Descalzo, M.Á., García Doval, I., and Borrego Hernando, L.

Published
2021
Full Text
View/download PDF

13. Recomendaciones del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC) de la AEDV en relación con la realización de pruebas epicutáneas durante la pandemia por SARS-CoV-2 (COVID-19)

Author

Armario Hita, José Carlos, Borrego Hernando, Leopoldo, Carrascosa Carrillo, José Manuel, Córdoba Guijarro, Susana, Curto, Laia, Fernández Redondo, Virginia, Figueras Nart, Ignasi, García Gavín, Juan, Elena Gatica Ortega, María, Giménez Arnau, Anna, Giménez Arnau, Elena, Gómez de la Fuente, Enrique, González Pérez, Ricardo, Heras Mendaza, Felipe, Hervella Garcés, Marcos, Manrique Martínez, Pilar, Mercader García, Pedro, Javier Ortiz de Frutos, Francisco, Miquel Miquel, Javier, Antonia Pastor Nieto, María, Rodríguez Serna, Mercedes, Ruíz González, Inmaculada, Sánchez Gilo, Araceli, Sánchez-Pedreño Guillén, Paloma, Sánchez Pérez, Javier, Sanz Sánchez, Tatiana, Serra-Baldrich, Esther, Silvestre Salvador, Juan Francisco, Zaragoza Ninet, Violeta, Carrascosa, J.M., Pastor-Nieto, M.A., Ruiz-González, I., Silvestre, J.F., Borrego, L., Gatica-Ortega, M.E., and Giménez-Arnau, A.M.

Published
2020
Full Text
View/download PDF

16. Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain

Author

Tous-Romero, F, Gimenez-Arnau, AM, Sanz-Sanchez, T, Perez, RG, Carrascosa-Carrillo, JM, Zaragoza-Ninet, V, Cordoba-Guijarro, S, Gatica-Ortega, ME, Miquel-Miquel, J, Borrego-Hernando, L, Ruiz-Gonzalez, I, Serra-Baldrich, E, Silvester-Salvador, JF, Mercader-Garcia, P, Sanchez-Perez, J, Rodriguez-Serna, M, Pastor-Nieto, A, Hervella-Garcia, M, Garcia-Doval, I, and Ortiz-de Frutos, FJ

Published
2022

18. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study

Author

Mercader-Garcia, P, Pastor-Nieto, MA, Gonzalez-Perez, R, Cordoba-Guijarro, S, Gimenez-Arnau, AM, Ruiz-Gonzalez, I, Mora-Fernandez, V, Miquel, J, Silvestre-Salvador, JF, Ortiz-Frutos, FJ, Sanz-Sanchez, T, Rodriguez-Serna, M, Perez-Feal, P, Sanchez-Perez, J, Heras-Mendaza, F, Serra-Baldrich, E, Zaragoza-Ninet, V, Hervella-Garces, M, Gatica-Ortega, ME, Garcia-Doval, I, Descalzo, MA, and Borrego, L

Subjects
patch tests, cross-sectional study, methyldibromo glutaronitrile, clinical relevance, allergic contact dermatitis
Abstract

Background Methyldibromo glutaronitrile (MDBGN) was one of the most frequent and relevant allergens found in patch testing at the beginning of this century. In 2008, this preservative was banned from cosmetics in Europe and ever since the prevalence of contact allergy to MDBGN has progressively decreased. Despite that gradual decline, MDBGN is still patch-tested in most baseline series. This study assessed the frequency of MDBGN sensitization, epidemiological characteristics of allergic patients, and the relevance of positive patch tests in a nationwide Spanish registry (REIDAC). Patients and methods We evaluated consecutively patch-tested patients in all participating centres. Using these data, we calculated the proportion of patients with positive patch tests to MDBGN from June 2018 to June 2020 and evaluated the relevance of the positive patch tests. Results One hundred and fourteen out of 5072 (2.24 %) tested patients were sensitized to MDBGN. Clinical current relevance was confirmed in only one case. Conclusion Although the frequency of contact allergy to MDBGN remains high, no clinical significance was found in most of these patients (5072 tests needed to obtain one relevant positive result). The clinical usefulness of this allergen seems weak and its continued inclusion in the European baseline series is questionable.

Published
2021

19. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC 1 national cross-sectional study

Author

Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Cordoba-Guijarro S, Jimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Ortiz-Frutos FJ, Sanz-Sanchez T, Rodriguez-Serna M, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Zaragoza-Ninet V, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Descalzo MÁ, and Borrego L

Subjects
Allergic contact dermatitis, clinical relevance, cross-sectional study, methyldibromo glutaronitrile, patch tests
Abstract

Methyldibromo glutaronitrile (MDBGN) was one of the most frequent and relevant allergens found in patch testing at the beginning of the 2000's. In 2008 this preservative was banned from cosmetics in Europe and ever since the prevalence of contact allergy to MDBGN progressively decreased. Despite that gradual decline, it is still patch-tested in most baseline series. This study assesses the frequency of MDBGN sensitization, epidemiological characteristics of allergic patients as well as the relevance of positive patch tests in a nationwide Spanish registry (REIDAC).

Published
2021

20. Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)

Author

Carrascosa J, Pastor-Nieto M, Ruiz-Gonzalez I, Silvestre J, Borrego L, Gatica-Ortega M, Gimenez-Arnau A, and Grp Espanol Invest Dermatitis Cont

Subjects
Contact, COVID-19, Dermatitis, Patch testing, Telemedicine
Abstract

As the COVID-19 pandemic gradually comes under control, the members of the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC) have drawn up a proposed list of the requirements, limitations, and conditioning factors affecting the resumption of work in contact dermatitis units. The assumption is that the severe acute respiratory syndrome coronavirus 2 is still circulating and that occasional or seasonal outbreaks will occur. They recommend that the first step should be to assess how many patch tests each clinic can handle and review the waiting list to prioritize cases according to disease severity and urgency. Digital technologies can, where possible, be used to send and receive the documentation necessary for the patch test (information, instructions, informed consent, etc.). If the necessary infrastructure is available, patients can be offered the option of a remote initial consultation. Likewise, in selected cases, the patch test results can be read in a virtual visit using photographs taken by the patient or a video visit can be scheduled to allow the physician to evaluate the site of application remotely. These measures will reduce the number of face-to-face visits required, but will not affect the time spent on each case, which must be scheduled in the normal manner. All of these recommendations are suggestions and should be adapted to the needs and possibilities of each health centre. (C) 2020 Published by Elsevier Espana, S.L.U.

Published
2020

30. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation".

Author

Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Sanz-Sanchez T, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, and Borrego L

Subjects
Humans, Nitriles, Patch Tests, Preservatives, Pharmaceutical, Dermatitis, Allergic Contact etiology
Published
2021
Full Text
View/download PDF

31. Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study.

Author

Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Cordoba-Guijarro S, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Ortiz-Frutos FJ, Sanz-Sanchez T, Rodriguez-Serna M, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Zaragoza-Ninet V, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Descalzo MÁ, and Borrego L

Subjects
Adult, Allergens, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Patch Tests statistics & numerical data, Cosmetics adverse effects, Dermatitis, Allergic Contact epidemiology, Nitriles adverse effects, Preservatives, Pharmaceutical adverse effects
Abstract

Background: Methyldibromo glutaronitrile (MDBGN) was one of the most frequent and relevant allergens found in patch testing at the beginning of this century. In 2008, this preservative was banned from cosmetics in Europe and ever since the prevalence of contact allergy to MDBGN has progressively decreased. Despite that gradual decline, MDBGN is still patch-tested in most baseline series. This study assessed the frequency of MDBGN sensitization, epidemiological characteristics of allergic patients, and the relevance of positive patch tests in a nationwide Spanish registry (REIDAC)., Patients and Methods: We evaluated consecutively patch-tested patients in all participating centres. Using these data, we calculated the proportion of patients with positive patch tests to MDBGN from June 2018 to June 2020 and evaluated the relevance of the positive patch tests., Results: One hundred and fourteen out of 5072 (2.24 %) tested patients were sensitized to MDBGN. Clinical current relevance was confirmed in only one case., Conclusion: Although the frequency of contact allergy to MDBGN remains high, no clinical significance was found in most of these patients (5072 tests needed to obtain one relevant positive result). The clinical usefulness of this allergen seems weak and its continued inclusion in the European baseline series is questionable., (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)

Published
2021
Full Text
View/download PDF

34. Treatment of lentigo maligna with azelaic acid.

Author

Rodríguez Prieto MA, Manchado Lopez P, Ruiz Gonzalez I, and Suarez D

Subjects
Aged, Female, Humans, Lentigo pathology, Male, Dermatologic Agents therapeutic use, Dicarboxylic Acids therapeutic use, Lentigo drug therapy, Melanoma drug therapy, Skin Neoplasms drug therapy
Published
1993
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results